Octavius Pharma has developed DC granules of Fenofibrate with Micronized Fenofibrate for making Fenofibrate Capsules/Tablets. Product has been developed by using Optimum Range of Micronized API to ensure proper Dissolution profile throughout shelf life. Finished capsules/Tablets specifications and dissolution profile is compliant to USP monograph.
| Strength | 145 / 160 / 200 mg |
| Finished Dosage Form | Tablets / Capsules |
| Finished Product Compliance | USP |
| API DMF | Available |
| CTD Dosssier | Available |
Fenofibrate: Fenofibrate is FDA approved medication for the management and treatment of hypertriglyceridemia, primary hypercholesterolemia, or mixed dyslipidemia. It reduces low-density lipoprotein, triglycerides, and total cholesterol while increasing high-density lipoprotein cholesterol.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields